Metabolomics insights into pathophysiological mechanisms of nephrology

International Urology and Nephrology

Volumn 46, Issue 5, 2014, Pages 1025-1030

  Zhang, Aihua ^a   Sun, Hui ^a   Qiu, Shi ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biomarkers; Kidney disease; Metabolites; Metabolomics; Nephrology

Indexed keywords

2 OXOISOCAPROIC ACID; 3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; ACYLCARNITINE; ALANINE; ARGININE; ASPARTIC ACID; BIOLOGICAL MARKER; CITRIC ACID; CREATINE; CREATININE; GALACTOSE; GLUTAMIC ACID; GLUTAMINE; GUANIDINOACETIC ACID; HOMOCYSTEINE; ISOLEUCINE; LACTIC ACID; LYSOPHOSPHATIDYLCHOLINE; MALIC ACID; OXALIC ACID; PURINE; PYROGLUTAMIC ACID; PYRUVIC ACID; SPERMIDINE; TRIMETHYLAMINE; TRIMETHYLAMINE OXIDE; UNINDEXED DRUG; VALINE;

ACUTE KIDNEY FAILURE; CANCER MORTALITY; CANCER SURVIVAL; CARBOHYDRATE METABOLISM; CHRONIC KIDNEY DISEASE; CONCEPTUAL FRAMEWORK; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HYPOURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LIPID METABOLISM; METABOLITE; METABOLOMICS; MICROALBUMINURIA; MOLECULAR DIAGNOSIS; NEPHROLITHIASIS; NEPHROLOGY; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIMARY RENAL HYPOURICEMIA; REVIEW; URINE VOLUME; ANIMAL; BLOOD; KIDNEY DISEASES; METABOLISM; PROCEDURES; URINE;

ANIMALS; BIOMARKERS; HUMANS; KIDNEY DISEASES; METABOLOMICS;

EID: 84903689352     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0600-2     Document Type: Review

References (40)

1. Weiss RH, Kim K (2011) Metabolomics in the study of kidney diseases. Nat Rev Nephrol 8(1):22-33
2. Zhong F, Liu X, Zhou Q, Hao X, Lu Y, Guo S, Wang W, Lin D, Chen N (2012) 1H NMR spectroscopy analysis of metabolites in the kidneys provides new insight into pathophysiological mechanisms: applications for treatment with Cordyceps sinensis. Nephrol Dial Transpl 27(2):556-565
3. Elewa U, Sanchez-Niño MD, Martin-Cleary C, Fernandez-Fernandez B, Egido J, Ortiz A (2012) Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled. Int Urol Nephrol 44(6):1731-1744
4. Wang X, Zhang A, Wang P, Sun H, Wu G, Sun W, Lv H, Jiao G, Xu H, Yuan Y, Liu L, Zou D, Wu Z, Han Y, Yan G, Dong W, Wu F, Dong T, Yu Y, Zhang S, Wu X, Tong X, Meng X (2013) Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies. Mol Cell Proteomics 12(5):1226-1238
5. Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM, Weiss RH (2009) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8(3):558-570
6. Sun H, Zhang A, Yan G, Piao C, Li W, Sun C, Wu X, Li X, Chen Y, Wang X (2013) Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 12(3):710-719
7. Urquidi V, Rosser CJ, Goodison S (2012) Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis. Curr Med Chem 19(22):3653-3663
8. Zhang A, Sun H, Han Y, Yan G, Wang X (2013) Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system. PLoS One 8(5):e64381
9. Wang X, Zhang A, Sun H (2013) Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology 57(5):2072-2077
10. Wang J, Zhou Y, Xu M, Rong R, Guo Y, Zhu T (2011) Urinary metabolomics in monitoring acute tubular injury of renal allografts: a preliminary report. Transpl Proc 43(10):3738-3742
11. Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T (2010) Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878(20):1662-1668
12. Brown MV, McDunn JE, Gunst PR, Smith EM, Milburn MV, Troyer DA, Lawton KA (2012) Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies. Genome Med 4(4):33
13. Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity. Pharmazie 67(2):99-105
14. Siew ED, Ware LB, Ikizler TA (2011) Biological markers of acute kidney injury. J Am Soc Nephrol 22(5):810-820
15. Rhee EP, Thadhani R (2011) New insights into uremia-induced alterations in metabolic pathways. Curr Opin Nephrol Hypertens 20(6):593-598
16. Rosner MH (2009) Urinary biomarkers for the detection of renal injury. Adv Clin Chem 49:73-97
17. Zhang A, Sun H, Han Y, Yuan Y, Wang P, Song G, Yuan X, Zhang M, Xie N, Wang X (2012) Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 137(18):4200-4208
18. Ganti S, Weiss RH (2011) Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol 29(5):551-557
19. Wang X, Zhang A, Sun H (2012) Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS 16(7-8):414-421
20. Slocum JL, Heung M, Pennathur S (2012) Marking renal injury: can we move beyond serum creatinine? Transl Res 159(4):277-289
21. Liu Y, Yan S, Ji C, Dai W, Hu W, Zhang W, Mei C (2012) Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury. Kidney Blood Press Res 35(5):373-381
22. Sun J, Shannon M, Ando Y, Schnackenberg LK, Khan NA, Portilla D, Beger RD (2012) Serum metabolomic profiles from patients with acute kidney injury: a pilot study. J Chromatogr B Analyt Technol Biomed Life Sci 893-894:107-113
23. Goek ON, Döring A, Gieger C, Heier M, Koenig W, Prehn C, Römisch-Margl W, Wang-Sattler R, Illig T, Suhre K, Sekula P, Zhai G, Adamski J, Köttgen A, Meisinger C (2012) Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 60(2):197-206
24. Qi S, Ouyang X, Wang L, Peng W, Wen J, Dai Y (2012) A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy. Clin Transl Sci 5(5):379-385
25. Gao H, Dong B, Jia J, Zhu H, Diao C, Yan Z, Huang Y, Li X (2012) Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases. J Cancer Res Clin Oncol 138(5):753-761
26. Lin L, Huang Z, Gao Y, Yan X, Xing J, Hang W (2011) LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. J Proteome Res 10(3):1396-1405
27. Zira AN, Theocharis SE, Mitropoulos D, Migdalis V, Mikros E (2010) (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. J Proteome Res 9(8):4038-4044
28. Catchpole G, Platzer A, Weikert C, Kempkensteffen C, Johannsen M, Krause H, Jung K, Miller K, Willmitzer L, Selbig J, Weikert S (2011) Metabolic profiling reveals key metabolic features of renal cell carcinoma. J Cell Mol Med 15(1):109-118
29. Toyohara T, Suzuki T, Akiyama Y, Yoshihara D, Takeuchi Y, Mishima E, Kikuchi K, Suzuki C, Tanemoto M, Ito S, Nagao S, Soga T, Abe T (2011) Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clin Exp Nephrol 15(5):676-687
30. Taylor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, Kim K, Weiss RH (2010) A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol Renal Physiol 298(4):F909-F922
31. Zhao T, Zhang H, Zhao T, Zhang X, Lu J, Yin T, Liang Q, Wang Y, Luo G, Lan H, Li P (2012) Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease. J Pharm Biomed Anal 60:32-43
32. Hirayama A, Nakashima E, Sugimoto M, Akiyama S, Sato W, Maruyama S, Matsuo S, Tomita M, Yuzawa Y, Soga T (2012) Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem 404(10):3101-3109
33. Garcia-Perez I, Villaseñor A, Wijeyesekera A, Posma JM, Jiang Z, Stamler J, Aronson P, Unwin R, Barbas C, Elliott P, Nicholson J, Holmes E (2012) Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model. J Proteome Res 11(9):4425-4435
34. Sui W, Li L, Che W, Guimai Z, Chen J, Li W, Dai Y (2012) A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy. Clinics (Sao Paulo) 67(4):363-373
35. Zhang H, Jia J, Cheng J, Ye F, Li X, Gao H (2012) 1H NMR-based metabonomics study on serum of renal interstitial fibrosis rats induced by unilateral ureteral obstruction. Mol BioSyst 8(2):595-601
36. Tzovaras VT, Psychogios NG, Kostara CE, Bairaktari ET, Elisaf MS (2009) Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study. NMR Biomed 22(10):1072-1083
37. Kim K, Taylor SL, Ganti S, Guo L, Osier MV, Weiss RH (2011) Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS 15(5):293-303
38. Wang X, Zhang A, Han Y, Wang P, Sun H, Song G, Dong T, Yuan Y, Yuan X, Zhang M, Xie N, Zhang H, Dong H, Dong W (2012) Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 11(8):370-380
39. Zhang AH, Sun H, Qiu S, Wang XJ (2013) NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magn Reson Chem 51(9): 549-556
40. Zhang AH, Sun H, Wang XJ (2013) Recent advances in metabolomics in neurological disease, and future perspectives. Anal Bioanal Chem 405(25):8143-8150